After Hunter became too weak to walk to classes, she underwent a blood test. When doctors received the results, they urged ...

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...

The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...

George Morford has a rare and aggressive form of leukemia, and his life could depend on a stem cell treatment. The challenge ...

Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common pediatric cancers and among the ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Infection was a leading cause of death in lower-risk myelodysplastic syndromes (MDS), highlighting the need for vigilant ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

She learned she had acute myeloid leukemia, an aggressive blood cancer. “I felt so scared. I kind of blacked out,” she recalls. “I was like, ‘There’s no way she just said that.